Perspective Therapeutics and Merck to test cancer drug combination

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/24/2026

1. SPY
2. META
3. PATH
4. USO
5. KBH
6. AZO
7. QQQ
8. ORCL
9. RCL
10. MCD

Go back to Perspective Therapeutics and Merck to test cancer drug combination
Merck & Co. (NYSE: MRK) Delayed: 148.08 --0 (-0%)
Previous Close $148.08    52 Week High $65.46 
Open $148.08    52 Week Low $47.97 
Day High $148.08    P/E 100.73 
Day Low $148.08    EPS $1.47 
Volume 1,323